Tempus AI TEM, an innovator in artificial intelligence-based healthcare solutions, has been attracting investors' interest ...

Shares of Tempus AI (NASDAQ:TEM) dropped 19% Tuesday, the day after the AI-focused healthcare company released a Q4 earnings ...

At this time, I would like to welcome everyone to the Tempus fourth-quarter 2024 financial results conference call. Thank you, Jason. Good afternoon and welcome to Tempus fourth-quarter 2024 ...

Tempus AI's Q4 financials were slightly below expectations but aligned with preliminary results. See why I remain bullish on ...

Tempus AI (TEM) reports Q4 earnings Monday, expected loss of 20 cents/share, $203.12M in revenues. Stock up 98.80% YTD.

EST Tempus AI (TEM) down 7% at $64.83 after Q4 earnings miss and guidanceDiscover the Best Stocks and Maximize Your Portfolio: See what ...

Tempus AI's slowing growth, cash flow issues, and net debt raise doubts about its sustainability. Explore key concerns and ...

Reports Q4 revenue $200.7M, consensus $202.8M. “Our performance in 2024 reflects the strength of our core businesses, as Genomics continued to ...

Would you like to be notified of the latest news and updates on the stock market?

Tempus AI Inc (TEM) reports impressive revenue growth, strategic acquisitions, and extended partnerships, setting the stage for a promising 2025.

Despite optimistic news from the CEO yesterday afternoon, the company's shares fell overnight and a major investment house ...

The health care technology company posted revenue of $200.7 million in the period. For the year, the company reported a loss of $705.8 million, or $6.23 per share. Revenue was reported as $693.4 ...